- About
- PsychU For You
- Topics
- Events
- Content
The Agitation In Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
The Agitation In Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition
Agitation is one of the most common neuropsychiatric symptoms of Alzheimer’s dementia, and one of the most complex, prominent, stressful, and costly aspects of care.1 Caregivers are often first to encounter agitation-associated behaviors and play a pivotal role in communicating these symptoms to healthcare providers (HCPs).2,3 Agitation associated with Alzheimer’s dementia (AAD) causes a significant clinical, humanistic, and economic burden on community, family, and professional caregivers.4,5,6,7 AAD is notably underdiagnosed, and most caregivers do not identify the breadth of signs/symptoms of agitation and are hesitant to discuss these behaviors with HCPs.8 Therefore, there’s a need for an easy, pragmatic screener to facilitate caregiver recognition of AAD and HCP discussions. AASC™, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders,9 was designed to assist caregivers in recognizing AAD. Dr. Carolyn Clevenger will discuss development of the AASC™ tool and its potential to improve communication between caregivers and providers, and ultimately recognition of agitation behaviors.
References:
- Halpern R, et al. Int J Geriatr Psychiatry. 2019;34(3):420-431
- Lindeza P, et al. BMJ Support Palliat Care. 2020; bmjspcare-2020-002242
- Gallego-Alberto L, et al. Clin Gerontol. 2022;45(5):1295-1303
- Fillit H, et al. Int J Geriatr Psychiatry. 2021 ;36(12) :1959-1969
- Jones E, et al. J Alzheimers Dis. 2021 ;83(1) :89-101
- Schein J, et al. J Alzheimers Dis. 2022 ;88(2) :663-677
- Palm R, et al. J Alzheimers Dis. 2018 ;66(4) :1463-1470
- Lanctot KL, et al. Alzheimers Dement (NY). 2017 ;3(3) :440-449
- Sano M, et al. International Psychogeriatrics 2023 :1-13. doi10.1017/S1041610222001041
Carolyn Clevenger, DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA
Professor of Transformative Clinical Practice, Emory University School of Nursing, Clinical Director and Gerontological Nurse Practitioner at Integrated Memory Care Clinic
MoreCarolyn Clevenger DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA, is Professor of Transformative Clinical Practice at the Emory University School of Nursing in Atlanta, Georgia. She serves as Clinical Director and Gerontological Nurse Practitioner at Emory’s Integrated Memory Care Clinic, a patient-centered medical home providing integrated memory care and primary care for persons living with dementia. She is a Past President of the Gerontological Advanced Practice Nurses Association, and Fellow of the American Association of Nurse Practitioners (AANP) and the Gerontological Society of America.
Mike Crooks, PharmD, BCGP (OPDC)
Senior Long-Term Care Medical Science Liaison
Speaker Carolyn Clevenger DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Moderator Mike Crooks, Pharm D, BCGP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Registration
- PsychU For You
